Search
for

    Glossary HMI-115

    HMI-115 is an investigational drug designed to target hair loss by promoting hair follicle regeneration and preventing further hair thinning. It works by modulating specific pathways involved in hair biology, particularly those related to the growth phase of hair follicles. This compound is relevant in the context of androgenetic alopecia and other forms of hair loss, as it aims to provide a novel therapeutic option that differs from traditional treatments like minoxidil and finasteride. Key distinguishing characteristics of HMI-115 include its unique mechanism of action and its potential to stimulate hair growth without the side effects commonly associated with existing hair loss treatments.

    Related Terms

    Learn 1

    1. HMI-115 Experimental antibody that blocks the prolactin receptor

    Community 10 of 26

    1. HopeMed (Hmi115) is pissed at Absci (Abs-201) Reddit · 30 Aug 2026
    2. Hope Medicine's HMI-115 could be out in 2027 per Company Founder Reddit · 25 May 2025
    3. Is hmi 115 the cure? Or is it 🧢 just like cosmeRNA, brezula, pyrilutamide, and other 📞 ies Reddit · 19 Jun 2024
    4. Would you continue to use Finasteride and Minoxidil once HMI 115 becomes available? Reddit · 24 May 2024
    5. Why TDM-105795 is not much talked about like GT20029 and HMI 115 despite having far better Trial results? Reddit · 11 May 2024
    6. HMI-115 update: Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia Reddit · 28 Oct 2023
    7. HMI-115 Australian Phase 1 Trial completed? Reddit · 18 Oct 2023
    8. Does anyone know when HMI-115 Phase 1 Australian study is supposed to end? Reddit · 4 Apr 2023
    9. What's going on with hmi115? The Phase 2 was concluded Nov2024 but no news Reddit · 2 Dec 2025
    10. Prolactin the Cause of Hair Loss? ABS-201 the Cure? Reddit · 16 Jul 2026
    All community results →

    Research 10 of 60

    1. The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms JEADV Clinical Practice · 2022 · 1 citations
    2. A Study on the Effectiveness and Safety of Herbal Extract Combination Compared to 3% Minoxidil Solution for the Treatment of Androgenetic Alopecia: A Randomized, Double-blind, Controlled Trial ˜The œOpen dermatology journal · 2024
    3. Emerging pharmacotherapies for Androgenetic Alopecia Expert Opinion on Pharmacotherapy · 2026
    4. Exhaustive analysis of scalp hair regression: subjective and objective perception from initial hair loss to severe miniaturisation and drug-induced regrowth Plastic and Aesthetic Research · 2021 · 3 citations
    5. Hypotensive Activity and Toxicology of Constituents from Bombax ceiba Stem Bark. Biological & Pharmaceutical Bulletin · 2003 · 58 citations
    6. The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology Best Practice & Research in Clinical Obstetrics & Gynaecology · 2004 · 131 citations
    7. Androgens in SARS-CoV-2 Coronavirus Infections Physiological Research · 2021 · 5 citations
    8. Comparative overview of phytoconstituents and pharmacological potential of Trigonella foenum-graecum leaves and seeds International Journal of Ayurvedic Medicine · 2025
    9. From a stem-cell–centered to a niche-centered view: the core role of collagen networks in hair loss and hair follicle miniaturization Frontiers in Cell and Developmental Biology · 2026
    10. Dermal EZH2 simultaneously orchestrates dermal differentiation and epidermal proliferation during murine skin development bioRxiv (Cold Spring Harbor Laboratory) · 2020
    All research results →